A study to evaluate the prevalence and distribution of steatotic and fibrotic liver disease across India

A retrospective cross-sectional observational multi-centric study to evaluate the prevalence and distribution of steatotic and fibrotic liver disease across India via vibration-controlled transient elastography parameters

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN18116615

Enrollment

15520

Registered

2024-08-06

Start date

2023-01-01

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver disease (NAFLD) Digestive System

Interventions

The study involves collecting data from patients who have already undergone the VCTE test between January 2023 and April 2024.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age >18 years 2. Patients who have given consent for the FIBROSCAN™ (VCTE) test

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women 2. Individuals with alcohol consumption of more than 30 g and 20 g per day

Design outcomes

Primary

Measure	Time frame
Prevalence of steatotic and fibrotic liver disease measured using Vibration Controlled Transient Elastography (VCTE) parameters, including Controlled Attenuation Parameter (CAP) and Liver Stiffness Measurement (LSM). Data were collected retrospectively from patients who underwent VCTE between January 2023 and April 2024.	—

Secondary

Measure	Time frame
Analysis of age-wise and gender-wise distribution conducted using deidentified patient data. This data was retrospectively collected from January 2023 to April 2024.	—

Countries

India

Contacts

Public ContactPrachi Sharma

patientsafety@tatvacare.in+91 (0)8290799906

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026